Enquyst Technologies
Enquyst Technologies is an innovative bioprocess and analytical technology company founded in 2017, dedicated to developing disruptive equipment and processes to improve biotherapeutic manufacturing. Their mission is to create high-quality, cost-effective biological therapies accessible worldwide by leveraging patented IPP technology that enables continuous manufacturing and ultra-high purity bioproducts.
Industries
Nr. of Employees
small (1-50)
Enquyst Technologies
600 Suffolk Street, 2nd Floor, Lowell, MA 01854
Patents
Process technology for biological product manufacturing and downstream purification
US-11639367-B2
View DetailsProcess technology for biological product manufacturing and downstream purification
US-11566043-B2
View DetailsProcess technology for biological product manufacturing and downstream purification
US-11396526-B2
View DetailsProcess technology for biological product manufacturing and downstream purification
US-11345723-B2
View Details
Process technology for biological product manufacturing and downstream purification
US-11639367-B2
View DetailsProcess technology for biological product manufacturing and downstream purification
US-11566043-B2
View DetailsProcess technology for biological product manufacturing and downstream purification
US-11396526-B2
View DetailsProcess technology for biological product manufacturing and downstream purification
US-11345723-B2
View DetailsProducts
Isoelectric point-based flow-through purification system (resin-free downstream purification platform)
A modular flow-through purification system that isolates and polishes target biomolecules by leveraging isoelectric point, charge heterogeneity and size; designed for continuous operation, small footprint, closed sterile fluid paths and integrated in-line monitoring.
Isoelectric point-based flow-through purification system (resin-free downstream purification platform)
A modular flow-through purification system that isolates and polishes target biomolecules by leveraging isoelectric point, charge heterogeneity and size; designed for continuous operation, small footprint, closed sterile fluid paths and integrated in-line monitoring.
Services
Process development for purification and polishing of biologics across modalities, including experimental design, DoE, and scale-up feedback for equipment design.
Development, qualification and validation of bioanalytical and physicochemical assays for biomolecule characterization and in-process testing, including GLP-compliant documentation and SOP authoring.
Mechanical and electrical engineering services for design, prototyping, testing and iteration of bioprocess equipment, including fluidics, liquid handling and automated control integration.
Pilot-scale deployment and testing of continuous, resin-free purification workflows intended to replace multiple chromatography unit operations and reduce consumables and footprint.
Process development for purification and polishing of biologics across modalities, including experimental design, DoE, and scale-up feedback for equipment design.
Development, qualification and validation of bioanalytical and physicochemical assays for biomolecule characterization and in-process testing, including GLP-compliant documentation and SOP authoring.
Mechanical and electrical engineering services for design, prototyping, testing and iteration of bioprocess equipment, including fluidics, liquid handling and automated control integration.
Pilot-scale deployment and testing of continuous, resin-free purification workflows intended to replace multiple chromatography unit operations and reduce consumables and footprint.
Expertise Areas
- Downstream process development
- Continuous biomanufacturing
- Process intensification for therapeutic proteins
- Analytical method development and validation
Key Technologies
- Isoelectric point-based flow-through purification
- Continuous downstream manufacturing platforms
- Process Analytical Technology (in-line monitoring)
- Tangential flow filtration (TFF) / UF-DF
News & Updates
Enquyst Technologies was selected as a Top Innovator in Biotech and Dr. Jason Criscione presented the company’s innovative IPP technology to healthcare investors.
Dr. Jason Criscione, Chief Scientific Officer of Enquyst Technologies, presented at the new TechBio Showcase to provide an update on the company's innovative IPP technology and its impact on biologics manufacturing.
Dr Jason Criscione presented on the application of Enquyst’s IPP technology in the manufacture of viral vectors.
Enquyst was selected as one of twenty small-to-medium manufacturing companies to present a lightning pitch and poster showcasing its process analytical technologies.
Dr. Jason Criscione presented at Biotech Showcase to update on the company's IPP technology and its impact on biologics manufacturing.
Enquyst was selected to give a presentation at the Innovation Start-up Showcase at Bioprocess International 2023.
Enquyst Technologies was selected as a Top Innovator in Biotech and Dr. Jason Criscione presented the company’s innovative IPP technology to healthcare investors.
Dr. Jason Criscione, Chief Scientific Officer of Enquyst Technologies, presented at the new TechBio Showcase to provide an update on the company's innovative IPP technology and its impact on biologics manufacturing.
Dr Jason Criscione presented on the application of Enquyst’s IPP technology in the manufacture of viral vectors.
Enquyst was selected as one of twenty small-to-medium manufacturing companies to present a lightning pitch and poster showcasing its process analytical technologies.
Dr. Jason Criscione presented at Biotech Showcase to update on the company's IPP technology and its impact on biologics manufacturing.
Enquyst was selected to give a presentation at the Innovation Start-up Showcase at Bioprocess International 2023.